Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Lucia Demková"'
Autor:
Tomasz Radaszkiewicz, Michaela Nosková, Kristína Gömöryová, Olga Vondálová Blanářová, Katarzyna Anna Radaszkiewicz, Markéta Picková, Ráchel Víchová, Tomáš Gybeľ, Karol Kaiser, Lucia Demková, Lucia Kučerová, Tomáš Bárta, David Potěšil, Zbyněk Zdráhal, Karel Souček, Vítězslav Bryja
Publikováno v:
eLife, Vol 10 (2021)
RNF43 is an E3 ubiquitin ligase and known negative regulator of WNT/β-catenin signaling. We demonstrate that RNF43 is also a regulator of noncanonical WNT5A-induced signaling in human cells. Analysis of the RNF43 interactome using BioID and immunopr
Externí odkaz:
https://doaj.org/article/429690658a42429e81ef4cee4109bc0b
Autor:
Lucia Demková, Andrea Šoltýsová, Viera Horváthová Kajabová, Zuzana Danková, Karin Jašek, Dana Dvorská, Pavel Babál, Alena Furdova, Bozena Smolkova
Publikováno v:
Acta Ophthalmologica. 100
Autor:
Andrea Soltysova, Dana Dvorska, Viera Horvathova Kajabova, Martina Pecimonova, Klaudia Cepcekova, Andrej Ficek, Lucia Demkova, Verona Buocikova, Pavel Babal, Ivan Juras, Katarina Janikova, Ivana Kasubova, Marek Samec, Dusan Brany, Darina Lyskova, Jela Valaskova, Zuzana Dankova, Bozena Smolkova, Alena Furdova
Publikováno v:
Clinical and Translational Medicine, Vol 13, Iss 7, Pp n/a-n/a (2023)
Externí odkaz:
https://doaj.org/article/8f36c6d2e6a640dfb570768ed66ab526
Autor:
Jana Jakubechova, Bozena Smolkova, Alena Furdova, Lucia Demkova, Ursula Altanerova, Andreas Nicodemou, Tatiana Zeleznikova, Daniela Klimova, Cestmir Altaner
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 16, p 12957 (2023)
Extracellular vesicles secreted from uveal melanoma (UM) cells are involved in the establishment of the premetastatic niche and display transforming potential for the formation of metastases, preferentially in the liver. In this study, we cultivated
Externí odkaz:
https://doaj.org/article/80a62db7831c46faa290e6410608a9e8
Autor:
Verona Buocikova, Silvia Tyciakova, Eleftherios Pilalis, Chara Mastrokalou, Maria Urbanova, Miroslava Matuskova, Lucia Demkova, Veronika Medova, Eleonora Marta Longhin, Elise Rundén-Pran, Maria Dusinska, Ivan Rios-Mondragon, Mihaela Roxana Cimpan, Alena Gabelova, Andrea Soltysova, Bozena Smolkova, Aristotelis Chatziioannou
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Decitabine (DAC), a DNA methyltransferase (DNMT) inhibitor, is tested in combination with conventional anticancer drugs as a treatment option for various solid tumors. Although epigenome modulation provides a promising avenue in treating resistant ca
Externí odkaz:
https://doaj.org/article/5bc2b77aace34b56b39120aa94a4b5ef
Autor:
Lucia Demkova, Lucia Kucerova
Publikováno v:
Molecular Cancer, Vol 17, Iss 1, Pp 1-14 (2018)
Abstract Metastatic disease in a cancer patient still remains a therapeutic challenge. Metastatic process involves many steps, during which malignant cells succeed to activate cellular pathways promoting survival in hostile environment, engraftment a
Externí odkaz:
https://doaj.org/article/a678f520a20d4d9594c5b307b523b79c
Autor:
Viera Horvathova Kajabova, Andrea Soltysova, Lucia Demkova, Paulina Plesnikova, Darina Lyskova, Alena Furdova, Pavel Babal, Bozena Smolkova
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 19, p 10748 (2021)
Uveal melanoma (UM) is an ocular tumor with a dismal prognosis. Despite the availability of precise molecular and cytogenetic techniques, clinicopathologic features with limited accuracy are widely used to predict metastatic potential. In 51 UM tissu
Externí odkaz:
https://doaj.org/article/e8cdc5166c6c48a29cffef1f923624dd
Autor:
Andrea Soltysova, Tatiana Sedlackova, Dana Dvorska, Karin Jasek, Pooneh Chokhachi Baradaran, Viera Horvathova Kajabova, Lucia Demkova, Verona Buocikova, Terezia Kurucova, Darina Lyskova, Alena Furdova, Gabriel Minarik, Pavel Babal, Zuzana Dankova, Bozena Smolkova
Publikováno v:
International Journal of Molecular Sciences, Vol 21, Iss 24, p 9651 (2020)
Despite outstanding advances in diagnosis and the treatment of primary uveal melanoma (UM), nearly 50% of UM patients develop metastases via hematogenous dissemination, driven by the epithelial-mesenchymal transition (EMT). Despite the failure in UM
Externí odkaz:
https://doaj.org/article/73fb154d5ed747cc9611bdd4fa091681